# Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)

> **NCT05364307** · — · COMPLETED · sponsor: **Global Alzheimer's Platform Foundation** · enrollment: 1555 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Memory Loss
- Memory Disorders
- Memory Impairment

## Interventions

- **OTHER:** Prescreener database

## Key facts

- **NCT ID:** NCT05364307
- **Lead sponsor:** Global Alzheimer's Platform Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-13
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 1555 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05364307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05364307, "Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05364307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*